DBMR - Diagnosis

Europe Pharmaceutical Isolator Market – Industry Trends and Forecast to 2026

  • Diagnosis
  • Published Report
  • Apr 2019
  • Europe
  • 350 Pages
  • No of Tables: 27
  • No of Figures: 133

Europe Pharmaceutical Isolator Market By Type (Aseptic Isolators, Containment Isolators, Bio Isolators, Sampling and Weighing Isolators, Active Pharmaceutical Ingredient (API) Manufacturing Isolators, Others), Product Class Type (ISO Class 5, Class III), System Type (Open System, Closed System), Pressure Difference (Positive Pressure, Negative Pressure), Configuration (Floor Standing, Mobile, Compact, Modular, Table Top, Portable), Application (Sterility Testing, Pharmaceutical Industry, Microbiology Safety Cabinets, Sampling/ Weighing/ Distribution, Animal Laboratories, Medical Device Manufacturing, Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, Academic and Research Institutes, Hospitals, Diagnostic Laboratories), Distribution Channel (Direct Tender, Retailer), Country (Germany, France, Italy, U.K., Spain, Switzerland, Russia, Netherlands, Belgium, Turkey, Rest of Europe) – Industry Trends and Forecast to 2026

Pharmaceutical isolators are used as an industrial barrier system to manufacture drugs in contamination free environment. The pharmaceutical isolators have various applications such as microbiological test, cell therapy processing, in production of the advanced therapy medicine products (ATMP) and in weighing, filling and dispensing of the injectable sterile products. Various companies are engaged in manufacturing the isolator for the pharmaceutical industry such as Getinge AB, Skan AG and Wabash National Corporation among others. The continuous development of the pharmaceutical market in developing and developed countries and growing research and development expenditure to develop innovative drugs are all enhancing the utilization of the pharmaceutical isolators. The advanced pharmaceutical isolators and their preferences by the pharma industries, leading the major manufactures to expand their business for the development and production of isolators. For instance, in May 2017, Skan AG (Switzerland) expanded their Germany site by constructing the production plants for the safety cabinets which is majorly engaged in manufacturing the pharmaceutical isolators.

Europe pharmaceutical isolator market is projected to register a substantial CAGR in the forecast period 2019 to 2026.

Segmentation: Europe Pharmaceutical Isolator Market

Europe pharmaceutical isolator market is segmented into eight notable segments which are type, product class type, system type, pressure difference, configuration, application, end user and distribution channel.

  • On the basis of type, the market is segmented into aseptic isolators, containment isolators, bio isolators, sampling and weighing isolators, active pharmaceutical ingredient (API) manufacturing isolators and others
  • On the basis of product class type, the market is segmented into Class III and ISO Class 5
  • On the basis of system type, the market is segmented into closed system and open system
  • On the basis of pressure difference, the market is segmented into positive pressure and negative pressure
  • On the basis of configuration, the market is segmented into floor standing, modular, mobile, compact, table top and portable
  • On the basis of application, the market is segmented into sterility testing, pharmaceutical industry, microbiology safety cabinets, sampling/ weighing/ distribution, animal laboratories, medical device manufacturing and others
  • On the basis of end user, the market is segmented into hospitals, diagnostic laboratories, academic and research institutes, pharmaceutical and biotechnology companies and contract research organization
  • On the basis of distribution channel, the market is segmented into direct tender and retailer

Competitive Analysis: Europe Pharmaceutical Isolator Market

Some of the major players operating in this market are Getinge AB, Chiyoda Corporation, Azbil Corporation, Germfree, MBRAUN, Wabash National Corporation, NuAire, ITECO s.r.l., COMECER S.p.A., Hosokawa, Hecht Technologie GmbH, Steriline S.r.l., Envair Limited, Vanrx Pharmasystems Inc., TEMA SINERGIE S.p.A, SKAN AG, Bioquell Inc., I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A., JACOMEX, Fedegari Autoclavi S.p.A, among others.

Recent Developments:

  • In May 2018, Azbil Telstar, S.L.  (Spain) showcase their product at Achema exhibition held in Germany. The company will show case their latest analytical technologies for pharmaceutical freeze drying systems and aseptic manufacturing processes.
  • In July 2017, Extract Technology Limited and CPi Technology announce that CPi Technology have been chosen as exclusive strategic agent in Ireland. This expansion will create strong geographical presence leading to growth of the company.

Research Methodology: Europe Pharmaceutical Isolator Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors and Pharmacologist, Industrialists.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

TABLE OF CONTENTS EUROPE PHARMACEUTICAL ISOLATOR MARKET

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY 1.2 MARKET DEFINITION 1.3 OVERVIEW OF EUROPE PHARMACEUTICAL ISOLATOR MARKET 1.4 CURRENCY AND PRICING 1.5 LIMITATIONS 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED 2.2 GEOGRAPHICAL SCOPE 2.3 YEARS CONSIDERED FOR THE STUDY 2.4 CURRENCY AND PRICING 2.5 RESEARCH METHODOLOGY 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7 DBMR MARKET POSITION GRID 2.8 DBMR VENDOR SHARE ANALYSIS 2.9 MULTIVARIATE MODELING 2.10 PRODUCTS LIFELINE CURVE 2.11 SECONDARY SOURCES 2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 GROWING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL SECTOR/INDUSTRY 3.1.2 LOW OPERATIONAL COST OF PHARMACEUTICAL ISOLATORS 3.1.3 INCREASING REGULATIONS AND COST OF NONCOMPLIANCE 3.1.4 HIGH MAINTENANCE OF ASEPTIC CONDITION IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS

3.2 RESTRAINT

3.2.1 STRINGENT GOVERNMENTAL REGULATIONS

3.3 OPPORTUNITIES

3.3.1 TECHNOLOGICAL ADVANCEMENTS IN PHARMACEUTICAL ISOLATORS 3.3.2 BUSINESS EXPANSION FOR THE PHARMACEUTICAL ISOLATORS

3.4 CHALLENGE

3.4.1 AVAILABILITY OF RESTRICTED ACCESS BARRIER SYSTEMS (RABS) FOR ASEPTIC PROCESSING

4 EXECUTIVE SUMMARY 5 PREMIUM INSIGHTS 6 INDUSTRY INSIGHTS 7 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY TYPE

7.1 OVERVIEW 7.2 ASEPTIC ISOLATORS 7.3 CONTAINMENT ISOLATORS 7.4 BIO ISOLATORS 7.5 SAMPLING AND WEIGHING ISOLATORS 7.6 ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS 7.7 OTHERS

8 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE

8.1 OVERVIEW 8.2 CLASS III 8.3 ISO CLASS 5

9 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE

9.1 OVERVIEW 9.2 CLOSED SYSTEM 9.3 OPEN SYSTEM

10 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE

10.1 OVERVIEW 10.2 POSITIVE PRESSURE 10.3 NEGATIVE PRESSURE

11 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION

11.1 OVERVIEW 11.2 FLOOR STANDING 11.3 MOBILE 11.4 COMPACT 11.5 MODULAR 11.6 TABLE TOP 11.7 PORTABLE

12 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION

12.1 OVERVIEW 12.2 STERILITY TESTING 12.3 PHARMACEUTICAL INDUSTRY 12.4 MICROBIOLOGY SAFETY CABINETS 12.5 SAMPLING/ WEIGHING/ DISTRIBUTION 12.6 ANIMAL LABORATORIES 12.7 MEDICAL DEVICE MANUFACTURING 12.8 OTHERS

13 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY END USER

13.1 OVERVIEW 13.2 HOSPITALS 13.3 DIAGNOSTIC LABORATORIES 13.4 ACADEMIC AND RESEARCH INSTITUTES 13.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 13.6 CONTRACT RESEARCH ORGANIZATION

14 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW 14.2 DIRECT TENDER 14.3 RETAILER

15 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY GEOGRAPHY

15.1 EUROPE

15.1.1 GERMANY 15.1.2 FRANCE 15.1.3 ITALY 15.1.4 U.K. 15.1.5 SPAIN 15.1.6 SWITZERLAND 15.1.7 RUSSIA 15.1.8 NETHERLANDS 15.1.9 BELGIUM 15.1.10 TURKEY 15.1.11 REST OF EUROPE

16 EUROPE PHARMACEUTICAL ISOLATORS MARKET, COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: EUROPE

17 COMPANY PROFILE

17.1 SKAN AG

17.1.1 COMPANY SNAPSHOT 17.1.2 SWOT ANALYSIS 17.1.3 COMPANY SHARE ANALYSIS 17.1.4 GEOGRAPHICAL PRESENCE 17.1.5 PRODUCT PORTFOLIO 17.1.6 RECENT DEVELOPMENTS 17.1.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

17.2 COMECER S.P.A.

17.2.1 COMPANY SNAPSHOT 17.2.2 SWOT ANALYSIS 17.2.3 COMPANY SHARE ANALYSIS 17.2.4 GEOGRAPHICAL PRESENCE 17.2.5 PRODUCT PORTFOLIO 17.2.6 RECENT DEVELOPMENTS 17.2.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

17.3 GETINGE AB.

17.3.1 COMPANY SNAPSHOT 17.3.2 SWOT ANALYSIS 17.3.3 REVENUE ANALYSIS 17.3.4 COMPANY SHARE ANALYSIS 17.3.5 GEOGRAPHICAL PRESENCE 17.3.6 PRODUCT PORTFOLIO 17.3.7 RECENT DEVELOPMENTS 17.3.8 DATA BRIDGE MARKET RESEARCH ANALYSIS

17.4 WABASH NATIONAL CORPORATION

17.4.1 COMPANY SNAPSHOT 17.4.2 SWOT ANALYSIS 17.4.3 REVENUE ANALYSIS 17.4.4 COMPANY SHARE ANALYSIS 17.4.5 GEOGRAPHICAL PRESENCE 17.4.6 PRODUCT PORTFOLIO 17.4.7 RECENT DEVELOPMENTS 17.4.8 DATA BRIDGE MARKET RESEARCH ANALYSIS

17.5 A. ROVANA LTD.

17.5.1 COMPANY SNAPSHOT 17.5.2 PRODUCT PORTFOLIO 17.5.3 RECENT DEVELOPMENTS

17.6 AZBIL CORPORATION

17.6.1 COMPANY SNAPSHOT 17.6.2 REVENUE ANALYSIS 17.6.3 GEOGRAPHICAL PRESENCE 17.6.4 PRODUCT PORTFOLIO 17.6.5 RECENT DEVELOPMENTS

17.7 BIOQUELL INC

17.7.1 COMPANY SNAPSHOT 17.7.2 GEOGRAPHICAL PRESENCE 17.7.3 PRODUCT PORTFOLIO 17.7.4 RECENT DEVELOPMENTS

17.8 CHIYODA CORPORATION

17.8.1 COMPANY SNAPSHOT 17.8.2 REVENUE ANALYSIS 17.8.3 GEOGRAPHICAL PRESENCE 17.8.4 PRODUCT PORTFOLIO 17.8.5 RECENT DEVELOPMENTS

17.9 ENVAIR LIMITED

17.9.1 COMPANY SNAPSHOT 17.9.2 GEOGRAPHICAL PRESENCE 17.9.3 PRODUCT PORTFOLIO 17.9.4 RECENT DEVELOPMENTS

17.10 ESCO GROUP OF COMPANIES

17.10.1 COMPANY SNAPSHOT 17.10.2 GEOGRAPHICAL PRESENCE 17.10.3 PRODUCT PORTFOLIO 17.10.4 RECENT DEVELOPMENT

17.11 FEDEGARI AUTOCLAVI S.P.A

17.11.1 COMPANY SNAPSHOT 17.11.2 GEOGRAPHICAL PRESENCE 17.11.3 PRODUCT PORTFOLIO 17.11.4 RECENT DEVELOPMENT

17.12 GERMFREE

17.12.1 COMPANY SNAPSHOT 17.12.2 PRODUCT PORTFOLIO 17.12.3 RECENT DEVELOPMENTS

17.13 HECHT TECHNOLOGIE GMBH

17.13.1 COMPANY SNAPSHOT 17.13.2 PRODUCT PORTFOLIO 17.13.3 RECENT DEVELOPMENTS

17.14 HOSOKAWA

17.14.1 COMPANY SNAPSHOT 17.14.2 REVENUE ANALYSIS 17.14.3 GEOGRAPHICAL PRESENCE 17.14.4 PRODUCT PORTFOLIO 17.14.5 RECENT DEVELOPMENTS

17.15 ITECO S.R.L.

17.15.1 COMPANY SNAPSHOT 17.15.2 GEOGRAPHICAL PRESENCE 17.15.3 PRODUCT PORTFOLIO 17.15.4 RECENT DEVELOPMENTS

17.16 I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A.

17.16.1 COMPANY SNAPSHOT 17.16.2 REVENUE ANALYSIS 17.16.3 GEOGRAPHICAL PRESENCE 17.16.4 PRODUCT PORTFOLIO 17.16.5 RECENT DEVELOPMENT

17.17 JACOMEX

17.17.1 COMPANY SNAPSHOT 17.17.2 GEOGRAPHICAL PRESENCE 17.17.3 PRODUCT PORTFOLIO 17.17.4 RECENT DEVELOPMENTS

17.18 MBRAUN

17.18.1 COMPANY SNAPSHOT 17.18.2 GEOGRAPHICAL PRESENCE 17.18.3 PRODUCT PORTFOLIO 17.18.4 RECENT DEVELOPMENTS

17.19 NUAIRE

17.19.1 COMPANY SNAPSHOT 17.19.2 PRODUCT PORTFOLIO 17.19.3 RECENT DEVELOPMENT

17.20 OPTIMA PACKAGING GROUP GMBH / METALL+PLASTIC GMBH

17.20.1 COMPANY SNAPSHOT 17.20.2 GEOGRAPHICAL PRESENCE 17.20.3 PRODUCT PORTFOLIO 17.20.4 RECENT DEVELOPMENTS

17.21 ROBERT BOSCH GMBH

17.21.1 COMPANYSNAPSHOT 17.21.2 REVENUE ANALYSIS 17.21.3 GEOGRAPHICAL PRESENCE 17.21.4 PRODUCT PORTFOLIO 17.21.5 RECENT DEVELOPMENTS

17.22 STERILINE S.R.L.

17.22.1 COMPANY SNAPSHOT 17.22.2 PRODUCT PORTFOLIO 17.22.3 RECENT DEVELOPMENTS

17.23 TAILIN

17.23.1 COMPANY SNAPSHOT 17.23.2 PRODUCT PORTFOLIO 17.23.3 RECENT DEVELOPMENTS

17.24 TEMA SINERGIE S.P.A

17.24.1 COMPANY SNAPSHOT 17.24.2 PRODUCT PORTFOLIO 17.24.3 RECENT DEVELOPMENTS

17.25 VANRX PHARMASYSTEMS INC.

17.25.1 COMPANY SNAPSHOT 17.25.2 PRODUCT PORTFOLIO 17.25.3 RECENT DEVELOPMENTS

18 CONCLUSION 19 QUESTIONNAIRE 20 RELATED REPORTS

LIST OF TABLES EUROPE PHARMACEUTICAL ISOLATOR MARKET

TABLE 1 OPERATING COSTS FOR ASEPTIC PRODUCTION UNDER RABS OR ISOLATOR TABLE 2 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY TYPE , 2017-2026 (USD MILLION) TABLE 3 EUROPE ASEPTIC ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 4 EUROPE CONTAINMENT ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 5 EUROPE BIO ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 6 EUROPE SAMPLING AND WEIGHING ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 7 EUROPE ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 8 EUROPE OTHERS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 9 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE , 2017-2026 (USD MILLION) TABLE 10 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, BY VOLUME, 2017-2026 (THOUSANDS UNIT) TABLE 11 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, BY ASP, 2017-2026 (USD) TABLE 12 EUROPE CLASS III IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 13 EUROPE ISO CLASS 5 IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 14 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 15 EUROPE CLOSED SYSTEM IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 16 EUROPE OPEN SYSTEM IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 17 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 18 EUROPE POSITIVE PRESSURE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 19 EUROPE NEGATIVE PRESSURE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 20 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 21 EUROPE FLOOR STANDING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 22 EUROPE MOBILE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 23 EUROPE COMPACT IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 24 EUROPE MODULAR IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 25 EUROPE TABLE TOP IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 26 EUROPE PORTABLE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 27 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 28 EUROPE STERILITY TESTING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 29 EUROPE PHARMACEUTICAL INDUSTRY IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 30 EUROPE MICROBIOLOGY SAFETY CABINETS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 31 EUROPE SAMPLING/ WEIGHING/ DISTRIBUTION IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 32 EUROPE ANIMAL LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 33 EUROPE MEDICAL DEVICE MANUFACTURING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 34 EUROPE OTHERS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 35 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY END USER , 2017-2026 (USD MILLION) TABLE 36 EUROPE HOSPITALS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 37 EUROPE DIAGNOSTIC LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 38 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 39 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 40 EUROPE CONTRACT RESEARCH ORGANIZATION IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 41 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 42 EUROPE DIRECT TENDER IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 43 EUROPE RETAILER IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 44 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 45 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 46 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 47 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 48 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 49 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 50 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 51 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 52 EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 53 GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 54 GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 55 GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 56 GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 57 GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 58 GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 59 GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 60 GERMANY PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 61 FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 62 FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 63 FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 64 FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 65 FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 66 FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 67 FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 68 FRANCE PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 69 ITALY PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 70 ITALY PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 71 ITALY PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 72 ITALY PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 73 ITALY PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 74 ITALY PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 75 ITALY PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 76 ITALY PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 77 U.K. PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 78 U.K. PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 79 U.K. PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 80 U.K. PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 81 U.K. PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 82 U.K. PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 83 U.K. PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 84 U.K. PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 85 SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 86 SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 87 SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 88 SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 89 SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 90 SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 91 SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 92 SPAIN PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 93 SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 94 SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 95 SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 96 SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 97 SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 98 SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 99 SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 100 SWITZERLAND PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 101 RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 102 RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 103 RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 104 RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 105 RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 106 RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 107 RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 108 RUSSIA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 109 NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 110 NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 111 NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 112 NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 113 NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 114 NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 115 NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 116 NETHERLANDS PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 117 BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 118 BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 119 BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 120 BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 121 BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 122 BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 123 BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 124 BELGIUM PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 125 TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION) TABLE 126 TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION) TABLE 127 TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION) TABLE 128 TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION) TABLE 129 TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION) TABLE 130 TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 131 TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 132 TURKEY PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 133 REST OF EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)

LIST OF FIGURES EUROPE PHARMACEUTICAL ISOLATOR MARKET

FIGURE 1 EUROPE PHARMACEUTICAL ISOLATOR MARKET: SEGMENTATION FIGURE 2 EUROPE PHARMACEUTICAL ISOLATOR MARKET: GEOGRAPHICAL SCOPE FIGURE 3 EUROPE PHARMACEUTICAL ISOLATOR MARKET: DATA TRIANGULATION FIGURE 4 EUROPE PHARMACEUTICAL ISOLATOR MARKET: DROC ANALYSIS FIGURE 5 EUROPE PHARMACEUTICAL ISOLATOR MARKET: EUROPE VS REGIONAL ANALYSIS FIGURE 6 EUROPE PHARMACEUTICAL ISOLATOR MARKET: COMPANY RESEARCH ANALYSIS FIGURE 7 EUROPE PHARMACEUTICAL ISOLATOR MARKET: INTERVIEWS BY REGION AND DESIGNATION FIGURE 8 EUROPE PHARMACEUTICAL ISOLATOR MARKET: DBMR MARKET POSITION GRID FIGURE 9 EUROPE PHARMACEUTICAL ISOLATOR MARKET: DBMR VENDOR SHARE ANALYSIS FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE PHARMACEUTICAL ISOLATOR MARKET FIGURE 11 EUROPE PHARMACEUTICAL ISOLATOR MARKET: MARKET SEGMENTATION FIGURE 12 GROWING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL AND HIGH MAINTAINACE OF ASEPTIC CONDITION IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS ARE EXPECTED TO DRIVE THE EUROPE PHARMACEUTICAL ISOLATOR MARKET IN THE FORECAST PERIOD O 2019 TO 2026 FIGURE 13 ASEPTIC ISOLATOR IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE PHARMACEUTICAL ISOLATOR MARKET IN 2019 & 2026 FIGURE 14 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY TYPE , 2018 FIGURE 15 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY PRODUCT CLASS TYPE, 2018 FIGURE 16 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY SYSTEM TYPE, 2018 FIGURE 17 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY PRESSURE DIFFERENCE, 2018 FIGURE 18 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY CONFIGURATION, 2018 FIGURE 19 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY APPLICATION, 2018 FIGURE 20 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY END USER, 2018 FIGURE 21 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY DISTRIBUTION CHANNEL, 2018 FIGURE 22 EUROPE PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2018) FIGURE 23 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018) FIGURE 24 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2019 & 2026) FIGURE 25 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018 & 2026) FIGURE 26 EUROPE PHARMACEUTICAL ISOLATOR MARKET: BY TYPE (2019-2026) FIGURE 27 EUROPE PHARMACEUTICAL ISOLATORS MARKET: COMPANY SHARE 2018 (%)

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $3200.00
  • $2500.00
BUY NOW ADD TO CART